Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer?

Open access

Abstract

Introduction The Eastern Cooperative Oncology Group (ECOG) score is a well known prognostic factor and almost always used to determine eligibility for clinical trials. The patient-rated performance status score (Pt-PS), section of the patient generated subjective global assessment scale, has identical criteria to the physician-rated ECOG scale (MD-PS). We compared the Pt-PS with MD-PS in patients with advanced non-small cell lung cancer and compared the effect of each rating on eligibility for a hypothetical clinical trial. Methods Consecutive patients with newly diagnosed advanced non-small cell lung cancer completed a patient generated subjective global assessment self-rated questionnaire, which was then correlated (kappa statistic) with the ECOG PS recorded at the same time. Patients were treated with standard chemotherapy. Survival was determined using Kaplan-Meier statistics. Results One hundred nine patients (M:F-54:55) were recruited. Pt-PS differed from MD-PS in 59 (54%) instances (p = 0.0001). When scores were not congruent, 41/59 (69%) patients evaluated themselves as having a worse PS than the physician's rating. Pt-PS was 0 to 1 in 60 (55%) patients whereas MD-PS was 0 to 1 in 78 (72%) patients. The functional status irrespective of evaluator was predictive of survival (p = 0.001 for MD-PS and p = 0.001 for Pt-PS). However, the median survival in those with MD-PS >/=2 was 3.3 (CI; 1.7-4.9) months whereas individuals with Pt-PS >/=2 had a median survival of 6.2 (CI…

Overview

Integrity signals

Registry

Crossref · 10.1097/jto.0b013e318186a272

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 18 references

Cited by

See all 74

Metadata

Authors
Dajczman, E., Kasymjanova, G., Kreisman, H., Swinton, N., Pepe, C., & Small, D.
Affiliations
Jewish General Hospital (CA)
Corresponding author
Dajczman, Esther
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2008-10
Volume
3
Issue
10
Pages
1133-1136
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2022463221
Cited by
74
References
18
Citations by year
2025: 4 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 6
FWCI
2.76
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Thoracic Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
Keywords
ECOG performance status, Subjective Global Assessment, non-small cell lung cancer, advanced lung cancer, functional status, patient self-assessment, inclusion and exclusion criteria, prognostic factors, survival, patient-physician agreement
MeSH terms
Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Combined Modality Therapy, Decision Making, Eligibility Determination, Female, Humans, Lung Neoplasms, Male, Physician-Patient Relations, Prognosis, Prospective Studies, Surveys and Questionnaires, Radiotherapy Dosage, Survival Rate, Pleural Effusion, Malignant, Karnofsky Performance Status, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer? https://app.cochat.ai/papers/10.1097/jto.0b013e318186a272
The paper
Dajczman, E., Kasymjanova, G., Kreisman, H., Swinton, N., Pepe, C., & Small, D. (2008). Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer? Journal of Thoracic Oncology. https://doi.org/10.1097/jto.0b013e318186a272

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.